Christer Larsson

2.3k total citations · 1 hit paper
35 papers, 1.8k citations indexed

About

Christer Larsson is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Christer Larsson has authored 35 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Christer Larsson's work include Protein Kinase Regulation and GTPase Signaling (8 papers), Neuroblastoma Research and Treatments (4 papers) and Ion channel regulation and function (4 papers). Christer Larsson is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (8 papers), Neuroblastoma Research and Treatments (4 papers) and Ion channel regulation and function (4 papers). Christer Larsson collaborates with scholars based in Sweden, United States and Denmark. Christer Larsson's co-authors include Hans‐Erik Åkerlund, Bertil Andersson, Per‐Åke Albertsson, Agneta Nordberg, Karin Jirström, Bengt Winblad, Bengt Hallberg, Sven Påhlman, Louise Cornmark and Anita Sjölander and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Cell Biology.

In The Last Decade

Christer Larsson

34 papers receiving 1.7k citations

Hit Papers

Natural History and Life Expectancy in Severe Alpha1‐Anti... 1978 2026 1994 2010 1978 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christer Larsson Sweden 20 849 404 347 229 228 35 1.8k
Hannelore Bauer Austria 26 902 1.1× 427 1.1× 182 0.5× 201 0.9× 259 1.1× 50 2.3k
Sandra E. Wilkinson United Kingdom 20 1.6k 1.9× 368 0.9× 287 0.8× 173 0.8× 305 1.3× 34 2.7k
Florian Überall Austria 30 1.6k 1.9× 512 1.3× 372 1.1× 356 1.6× 153 0.7× 64 2.7k
Sung‐Il Yang South Korea 14 1.8k 2.1× 395 1.0× 222 0.6× 261 1.1× 224 1.0× 20 2.6k
Bernard Rothhut France 27 1.2k 1.4× 169 0.4× 268 0.8× 164 0.7× 96 0.4× 53 1.8k
Elizabeth A. Allegretto United States 25 1.9k 2.3× 459 1.1× 317 0.9× 213 0.9× 256 1.1× 35 3.3k
Marta García‐Ramírez Spain 34 2.0k 2.3× 299 0.7× 201 0.6× 164 0.7× 172 0.8× 66 3.8k
Erica Werner United States 23 1.5k 1.7× 334 0.8× 489 1.4× 490 2.1× 232 1.0× 44 2.6k
Oliver M. Fischer Germany 16 1.4k 1.7× 1.1k 2.6× 305 0.9× 155 0.7× 360 1.6× 25 2.8k
Jessie M. English United States 19 2.2k 2.6× 496 1.2× 391 1.1× 348 1.5× 184 0.8× 24 2.9k

Countries citing papers authored by Christer Larsson

Since Specialization
Citations

This map shows the geographic impact of Christer Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christer Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christer Larsson more than expected).

Fields of papers citing papers by Christer Larsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christer Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christer Larsson. The network helps show where Christer Larsson may publish in the future.

Co-authorship network of co-authors of Christer Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Christer Larsson. A scholar is included among the top collaborators of Christer Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christer Larsson. Christer Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yinxi, Kimmo Kartasalo, Balázs Ács, et al.. (2021). Predicting Molecular Phenotypes from Histopathology Images: A Transcriptome-Wide Expression–Morphology Analysis in Breast Cancer. Cancer Research. 81(19). 5115–5126. 41 indexed citations
2.
Cornmark, Louise, et al.. (2016). Molecular characterization of protein kinase C delta (PKCδ)-Smac interactions. BMC Biochemistry. 17(1). 11–11. 4 indexed citations
3.
Allaoui, Roni, Caroline Bergenfelz, Sofie Mohlin, et al.. (2016). Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers. Nature Communications. 7(1). 13050–13050. 145 indexed citations
4.
Masoumi, Katarzyna Chmielarska, et al.. (2012). Identification of a novel protein kinase Cδ–Smac complex that dissociates during paclitaxel‐induced cell death. FEBS Letters. 586(8). 1166–1172. 11 indexed citations
5.
Cornmark, Louise, et al.. (2010). PKCα expression is a marker for breast cancer aggressiveness. Molecular Cancer. 9(1). 76–76. 92 indexed citations
6.
Larsson, Christer, et al.. (2008). Protein kinase Cepsilon is important for migration of neuroblastoma cells. BMC Cancer. 8(1). 365–365. 16 indexed citations
7.
Larsson, Christer. (2005). Protein kinase C and the regulation of the actin cytoskeleton. Cellular Signalling. 18(3). 276–284. 312 indexed citations
8.
Larsson, Christer, et al.. (2003). Preclinical in vivo pharmacology of BVT933, a selective 5 - HT2C receptor agonist. 5099. 1 indexed citations
9.
Edsjö, Anders, Erik Lavenius, Helén Nilsson, et al.. (2003). Expression of trkB in Human Neuroblastoma in Relation to MYCN Expression and Retinoic Acid Treatment. Laboratory Investigation. 83(6). 813–823. 54 indexed citations
10.
Larsson, Christer, et al.. (2003). A protein kinase Cβ inhibitor attenuates multidrug resistance of neuroblastoma cells. BMC Cancer. 3(1). 10–10. 19 indexed citations
11.
Thodeti, Charles K., Reidar Albrechtsen, Morten Grauslund, et al.. (2003). ADAM12/Syndecan-4 Signaling Promotes β1Integrin-dependent Cell Spreading through Protein Kinase Cα and RhoA. Journal of Biological Chemistry. 278(11). 9576–9584. 96 indexed citations
12.
Edsjö, Anders, et al.. (2001). Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.. PubMed. 12(1). 39–50. 24 indexed citations
13.
Larsson, Christer, Andrew P. Thomas, & Jan B. Hoek. (1998). Carbachol‐Stimulated Ca2+ Increase in Single Neuroblastoma SH‐SY5Y Cells: Effects of Ethanol. Alcoholism Clinical and Experimental Research. 22(3). 637–645. 7 indexed citations
14.
Larsson, Christer, et al.. (1993). An okadaic acid-sensitive protein phosphatase counteracts protein kinase C-induced phosphorylation in SH-SY5Y cells. Cellular Signalling. 5(3). 305–313. 6 indexed citations
15.
Nyberg, Fred & Christer Larsson. (1992). β-CASOMORPHINS AND THEIR SIGNIFICANCE IN BEHAVIOURAL PROCESSES. Clinical Neuropharmacology. 15. 54A–55A. 2 indexed citations
17.
Albertsson, Per‐Åke, Bertil Andersson, Christer Larsson, & Hans‐Erik Åkerlund. (1982). Phase Partition—A Method for Purification and Analysis of Cell Organelles and Membrane Vesicles. Methods of biochemical analysis. 28. 115–150. 126 indexed citations
18.
Nordberg, Agneta, Göran Wahlström, & Christer Larsson. (1980). Increased number of muscarinic binding sites in brain following chronic barbiturate treatment to rat. Life Sciences. 26(3). 231–237. 25 indexed citations
19.
Wildner, Günter F. & Christer Larsson. (1979). Effects of Glycidate on Carbon Dioxide Fixation with Isolated Spinach Chloroplasts. PLANT PHYSIOLOGY. 63(5). 887–891. 2 indexed citations
20.
Larsson, Christer. (1978). Natural History and Life Expectancy in Severe Alpha1‐Antitrypsin Deficiency, Pi Z. Acta Medica Scandinavica. 204(1-6). 345–351. 364 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026